Printer Friendly

Biotec, Affymetrix ink agreement for SAP enzyme deliveries.

M2 PHARMA-September 26, 2011-Biotec, Affymetrix ink agreement for SAP enzyme deliveries(C)2011 M2 COMMUNICATIONS

26 September 2011 - Norwegian biopharmaceutical company Biotec Pharmacon ASA (OSL:BIOTEC) said yesterday that its unit ArcticZymes AS and US DNA microarrays maker Affymetrix Inc (NASDAQ:AFFX) had entered into a new non-exclusive supply agreement for deliveries of ArcticZymes' enzyme Shrimp Alkaline Phosphatase (SAP).

Previously, Affymetrix had an exclusive right to distribute SAP. The current agreement allows ArcticZymes to offer SAP to other customers. However, it provides Affymetrix with a secure long-term supply of the enzyme at competitive prices by December 2017.

Currently, ArcticZymes is working to build SAP's distribution organisation and to increase sales and marketing capabilities as the enzyme continues to be its top-selling product accounting for the majority of its total sales.

((Comments on this story may be sent to info@m2.com)).END.PUB430>PDSeptember 26, 2011>JNM2 PHARMA.PRICEDATENOT APPLICABLE.DAY

COPYRIGHT 2011 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Sep 26, 2011
Words:151
Previous Article:Novartis' Afinitor meets primary endpoint in Phase III trial in patients with kidney tumours.
Next Article:Genentech's T-DM1 shows positive results in Phase II study in patients with mBC.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters